Inclusion Criteria:~1. With either gender aged at least 40 years old~2. With a diagnosis of one of the
following disease i. Vascular dementia according to the NINDS-AIREN International Workshop criteria or ii.
Alzheimer's disease according to the NIAAA criteria iii. Mixed dementia (possible Alzheimer's disease with
cerebrovascular disease) according to the NIAAA criteria~ Note:~ 1. NINDS-AIREN: National Institute of
Neurological Disorders and Stroke and Association Internationale pour la Recherche et l'Enseignement en
Neurosciences~ 2. NIAAA: National Institute on Aging-Alzheimer's Association~3. With mild-to-moderate dementia
(score of the Mini-Mental State Examination (MMSE) defined as between 10 to 24 and score of ADAS-Cog as at
least 12)~4. Able to read, write, communicate, and understand cognitive testing instructions~5. Having a
responsible caregiver who spends at least 4 hours daily with the patient. The caregiver will accompany the
patient to all study visits, , supervise administration of study drug, and be able to assess the patient's
condition~6. Patients and the responsible caregiver willing and able to provide written informed consent form~
